Two New Studies on Astaxanthin, and What They Actually Found

Two major astaxanthin studies caught my eye recently, one looked at skin while the other looked at the heart.
The first is a randomized, double-blind, placebo-controlled trial, the gold standard of research, published in the Journal of Medicinal Food. Researchers recruited 44 healthy people with moderately sun-aged skin and gave them either a daily combination of astaxanthin at 2 mg and collagen hydrolysate at 3 grams, or a matching placebo, for 12 weeks. What makes this one interesting is that it tested the two together, rather than either one alone.

The results in the supplement group, compared to placebo, were genuinely encouraging. Their facial skin showed significant improvements in elasticity, that springy, bounce-back quality we associate with youthful skin.  Their skin barrier improved too, measured as reduced water loss through the skin, which means better hydration and resilience.

The most fascinating part was what happened at the molecular level. In the supplement group, the skin’s own production of procollagen, the raw precursor to collagen, increased markedly, by more than threefold in UV-exposed skin. The enzymes that break skin down were suppressed. The main collagen-degrading enzyme, called MMP-1, dropped by 68 percent, and MMP-12, which breaks down elastin, dropped by 77 percent. In plain terms, the skin was building more of its own scaffolding and tearing down less of it.

Astaxanthin and Inflammation in Heart Patients

The second study, published more recently in Scientific Reports, looked somewhere very different. It was also a randomized, double-blind, placebo-controlled trial, this time in 80 patients with chronic heart failure. They received either 20 mg of astaxanthin per day or a placebo for 8 weeks, and the researchers measured markers of inflammation and oxidative stress.

The astaxanthin group showed significant reductions in several key inflammatory markers, including TNF-alpha, MCP-1, and hs-CRP, all of which are signals of inflammation in the body. Their antioxidant capacity improved, and markers of oxidative stress fell. The patients also reported improvements in symptoms like fatigue and shortness of breath compared to those on placebo. The researchers concluded that astaxanthin’s antioxidant and anti-inflammatory properties may be worth further study in this setting.

Please read this carefully
This study was conducted in people already diagnosed with a serious heart condition, under medical care. It is not a recommendation, and astaxanthin is not a treatment for heart failure or any disease. If you have a heart condition, please do not add or change anything in your routine based on a single study. Talk with your cardiologist, who knows your full picture and your medications. 

What Connects the Two

At first glance, skin and heart seem unrelated.  The thread running through both studies is the same, and it is the reason astaxanthin behaves the way it does across so many different tissues. That thread is oxidative stress and inflammation.

Astaxanthin is an unusually powerful antioxidant, and its structure lets it embed into cell membranes and work in places many antioxidants cannot reach. In the skin study, calming oxidative and inflammatory damage appears to have helped the skin build collagen and preserve elastin. In the heart study, that same antioxidant and anti-inflammatory action showed up as lower inflammatory markers. One molecule, one underlying mechanism, showing up in two very different parts of the body. That is what makes astaxanthin such an interesting subject for researchers.

The Bottom Line
What I appreciate about these two studies, side by side, is how they capture why astaxanthin keeps earning scientific attention. A humble pigment born in algae, quietly showing up in research on skin that ages more gracefully and on the deep chemistry of inflammation. The research on this remarkable red molecule is far from finished, and I will keep reporting it as it comes.
To your health and your curiosity,
Naomi

1.    Yoon HS, Cho HH, Cho S, Lee SR, Shin MH, Chung JH. Supplementing with dietary astaxanthin combined with collagen hydrolysate improves facial elasticity and decreases matrix metalloproteinase-1 and -12 expression: a comparative study with placebo. J Med Food. 2014;17(7):810–816.

2.    Ghotboddin Mohammadi S, Shafie D, Feizi A, et al. The effect of astaxanthin supplementation on inflammatory markers, lipid profile, and anthropometric indices in patients with heart failure: a randomized controlled trial. Sci Rep. 2026;16:27593.

3.    Davinelli S, Nielsen ME, Scapagnini G. Astaxanthin in skin health, repair, and disease: a comprehensive review. Nutrients. 2018;10(4):522.

4.    Fassett RG, Coombes JS. Astaxanthin: a potential therapeutic agent in cardiovascular disease. Mar Drugs. 2011;9(3):447–465.

5.    Kishimoto Y, Yoshida H, Kondo K. Potential anti-atherosclerotic properties of astaxanthin. Mar Drugs. 2016;14(2):35.

This article is for educational and informational purposes only and is not medical advice. Statements have not been evaluated by the Food and Drug Administration. Astaxanthin is not intended to diagnose, treat, cure, or prevent any disease, including heart disease. The research described here, particularly in patients with heart failure, is early and does not constitute a treatment recommendation. Always consult your healthcare provider before starting any supplement, especially if you have a medical condition or take medication.